Hantech Bio-Technology (1294.TWO) Earnings Analysis
Hantech Bio-Technology (1294.TWO) next reports earnings on 2026-08-17. Last quarter (2026-03-03) it missed with EPS 1.23 TWD vs 1.51 TWD est (-18.5%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E 11.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1294.TWO next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
1294.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-03 | 1.23 TWD | 1.51 TWD | -18.5% | Miss |
| 2024-12-31 | 1.12 TWD | 1.51 TWD | -25.8% | Miss |
| 2024-11-14 | 1 TWD | 1.44 TWD | -30.6% | Miss |
| 2024-11-07 | 1.37 TWD | 1.32 TWD | +3.8% | Beat |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
1294.TWO valuation and analyst view
| Trailing P/E | 11.71 |
|---|---|
| Trailing EPS | 4.938 TWD |
| Price / book | 1.95 |
| Dividend yield | 5.35% |
| Market cap | 1.71B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Hantech Bio-Technology (1294.TWO)'s next earnings date?
Hantech Bio-Technology is next scheduled to report on 2026-08-17.
Did 1294.TWO beat earnings last quarter?
In its 2026-03-03 report, 1294.TWO posted EPS of 1.23 TWD versus a 1.51 TWD estimate — a miss of 18.5%.
What is 1294.TWO's earnings track record?
Over the last 4 reported quarters with consensus data, 1294.TWO beat estimates 1 times (25%).
What is 1294.TWO's current P/E ratio and EPS?
1294.TWO trades at a trailing P/E of 11.71 on trailing EPS of 4.9378939378939375 TWD.
What do analysts rate 1294.TWO?
1294.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.